| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |





From the Department of Anatomy and Cell Biology,*
Division of Medical Cell Biology, University of Heidelberg, Heidelberg,
Germany; the Laboratory of Clinical Chemistry,
Faculty of Pharmacy, Katholieke Universiteit Leuven, Leuven, Belgium;
the Department of Life Sciences,
Janssen
Research Foundation, Beerse, Belgium; and the Department of Molecular
Cell Biology,
Maastricht University,
Maastricht, The Netherlands
Zellweger syndrome (cerebro-hepato-renal syndrome) is the most severe form of the peroxisomal biogenesis disorders leading to early death of the affected children. To study the pathogenetic mechanisms causing organ dysfunctions in Zellweger syndrome, we have recently developed a knockout-mouse model by disrupting the PEX5 gene, encoding the targeting receptor for most peroxisomal matrix proteins (M Baes, P Gressens, E Baumgart, P Carmeliet, M Casteels, M Fransen, P Evrard, D Fahimi, PE Declercq, D Collen, PP van Veldhoven, GP Mannaerts: A mouse model for Zellweger syndrome. Nat Genet 1997, 17:49571 ). In this study, we present evidence that the absence of functional peroxisomes, causing a general defect in peroxisomal metabolism, leads to proliferation of pleomorphic mitochondria with severe alterations of the mitochondrial ultrastructure, changes in the expression and activities of mitochondrial respiratory chain complexes, and an increase in the heterogeneity of the mitochondrial compartment in various organs and specific cell types (eg, liver, proximal tubules of the kidney, adrenal cortex, heart, skeletal and smooth muscle cells, neutrophils). The changes of mitochondrial respiratory chainenzymes are accompanied by a marked increase ofmitochondrial manganese-superoxide dismutase, asrevealed by in situ hybridization and immunocytochemistry, suggesting increased production of reactive oxygen species in altered mitochondria. This increased oxidative stress induced probably by defective peroxisomal antioxidant mechanisms combined with accumulation of lipid intermediates of peroxisomal ß-oxidation system could contribute significantly to the pathogenesis of multiple organ dysfunctions in Zellweger syndrome.
This article has been cited by other articles:
![]() |
S. Hein, P. Schonfeld, S. Kahlert, and G. Reiser Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture Hum. Mol. Genet., June 15, 2008; 17(12): 1750 - 1761. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ferrer, J. P. Kapfhammer, C. Hindelang, S. Kemp, N. Troffer-Charlier, V. Broccoli, N. Callyzot, P. Mooyer, J. Selhorst, P. Vreken, et al. Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage Hum. Mol. Genet., December 1, 2005; 14(23): 3565 - 3577. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Oezen, W. Rossmanith, S. Forss-Petter, S. Kemp, T. Voigtlander, K. Moser-Thier, R. J. Wanders, R. E. Bittner, and J. Berger Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency Hum. Mol. Genet., May 1, 2005; 14(9): 1127 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Kovacs, J. E. Shackelford, K. N. Tape, M. J. Richards, P. L. Faust, S. J. Fliesler, and S. K. Krisans Disturbed Cholesterol Homeostasis in a Peroxisome-Deficient PEX2 Knockout Mouse Model Mol. Cell. Biol., January 1, 2004; 24(1): 1 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jia, C. Qi, Z. Zhang, T. Hashimoto, M. S. Rao, S. Huyghe, Y. Suzuki, P. P. Van Veldhoven, M. Baes, and J. K. Reddy Overexpression of Peroxisome Proliferator-activated Receptor-{alpha} (PPAR{alpha})-regulated Genes in Liver in the Absence of Peroxisome Proliferation in Mice Deficient in both L- and D-Forms of Enoyl-CoA Hydratase/Dehydrogenase Enzymes of Peroxisomal {beta}-Oxidation System J. Biol. Chem., November 21, 2003; 278(47): 47232 - 47239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Janssen, P. Gressens, M. Grabenbauer, E. Baumgart, A. Schad, I. Vanhorebeek, A. Brouwers, P. E. Declercq, D. Fahimi, P. Evrard, et al. Neuronal Migration Depends on Intact Peroxisomal Function in Brain and in Extraneuronal Tissues J. Neurosci., October 29, 2003; 23(30): 9732 - 9741. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maxwell, J. Bjorkman, T. Nguyen, P. Sharp, J. Finnie, C. Paterson, I. Tonks, B. C. Paton, G. F. Kay, and D. I. Crane Pex13 Inactivation in the Mouse Disrupts Peroxisome Biogenesis and Leads to a Zellweger Syndrome Phenotype Mol. Cell. Biol., August 15, 2003; 23(16): 5947 - 5957. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Bushdid, H. Osinska, R. R. Waclaw, J. D. Molkentin, and K. E. Yutzey NFATc3 and NFATc4 Are Required for Cardiac Development and Mitochondrial Function Circ. Res., June 27, 2003; 92(12): 1305 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. McGuinness, J.-F. Lu, H.-P. Zhang, G.-X. Dong, A. K. Heinzer, P. A. Watkins, J. Powers, and K. D. Smith Role of ALDP (ABCD1) and Mitochondria in X-Linked Adrenoleukodystrophy Mol. Cell. Biol., January 15, 2003; 23(2): 744 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, E. Baumgart, J. C. Morrell, G. Jimenez-Sanchez, D. Valle, and S. J. Gould PEX11{beta} Deficiency Is Lethal and Impairs Neuronal Migration but Does Not Abrogate Peroxisome Function Mol. Cell. Biol., June 15, 2002; 22(12): 4358 - 4365. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |